NCT02146274

Brief Summary

PROSPER (Patient-centered Research into Outcomes Stroke patients Prefer and Effectiveness Research) is a three year research project to create a national, sustainable model to improve decision-making and patient-centered stroke outcomes through comparative effectiveness research.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,877

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2013

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

May 21, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 23, 2014

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2017

Completed
1.6 years until next milestone

Results Posted

Study results publicly available

July 26, 2019

Completed
Last Updated

August 6, 2019

Status Verified

August 1, 2019

Enrollment Period

4.2 years

First QC Date

May 21, 2014

Results QC Date

March 5, 2018

Last Update Submit

August 2, 2019

Conditions

Keywords

PROSPERStrokeIschemic Stroke

Outcome Measures

Primary Outcomes (1)

  • Depression

    Patient Health Questionnaire - 2 Item (PHQ-2) Higher score suggests more depression; range of 0-6. A score of two or higher suggests a diagnosis of major depression.

    6 months after enrollment

Secondary Outcomes (1)

  • Functional Status

    6 months after enrollment

Study Arms (1)

Ischemic Stroke Patients

Patients who have had an ischemic stroke that are hospitalized in an acute-care setting.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Ischemic Stroke patients

You may qualify if:

  • Ability to give informed consent or the availability of a surrogate who can consent on the patient's behalf.

You may not qualify if:

  • Patients with subarachnoid or intracerebral hemorrhage
  • Patients with transient ischemic attack (TIA)
  • Patients with expected survival less than 6 months/discharged to hospice

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke Clinical Research Institute

Durham, North Carolina, 27705, United States

Location

Related Publications (2)

  • Xian Y, Wu J, O'Brien EC, Fonarow GC, Olson DM, Schwamm LH, Bhatt DL, Smith EE, Suter RE, Hannah D, Lindholm B, Maisch L, Greiner MA, Lytle BL, Pencina MJ, Peterson ED, Hernandez AF. Real world effectiveness of warfarin among ischemic stroke patients with atrial fibrillation: observational analysis from Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) study. BMJ. 2015 Jul 31;351:h3786. doi: 10.1136/bmj.h3786.

  • Xian Y, O'Brien EC, Fonarow GC, Olson DM, Schwamm LH, Hannah D, Lindholm B, Maisch L, Lytle BL, Greiner MA, Wu J, Peterson ED, Pencina MJ, Hernandez AF. Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research: Implementing the patient-driven research paradigm to aid decision making in stroke care. Am Heart J. 2015 Jul;170(1):36-45, 45.e1-11. doi: 10.1016/j.ahj.2015.04.008. Epub 2015 Apr 18.

MeSH Terms

Conditions

StrokeIschemic Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Limitations and Caveats

6 month prospective observational study. Patients not randomized

Results Point of Contact

Title
Vice Dean of Clinical Research
Organization
Duke University School of Medicine

Study Officials

  • Adrian Hernandez, MD

    DCRI

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 21, 2014

First Posted

May 23, 2014

Study Start

November 1, 2013

Primary Completion

December 31, 2017

Study Completion

December 31, 2017

Last Updated

August 6, 2019

Results First Posted

July 26, 2019

Record last verified: 2019-08

Locations